Sign In
Buy BIIB
$196.45
+0.490 (+0.250%)
At Close: Jun 04, 2026
Levi & Korsinsky Announces the Filing of a Securities Class Action on Behalf of Biogen Inc.(BIIB) Shareholders
11:15am, Friday, 28'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
LOS ANGELES, CA / ACCESSWIRE / June 28, 2024 / The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. ("Biogen" or "the Co
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Against Biogen Inc. (BIIB)
11:00am, Friday, 28'th Jun 2024
LOS ANGELES, June 28, 2024 (GLOBE NEWSWIRE) -- Glancy Prongay & Murray LLP (“GPM”) reminds investors of the upcoming July 22, 2024 deadline to file a lead plaintiff motion in the class action fil
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
Shareholders that lost money on Biogen Inc. (BIIB) Urged to Join Class Action - Contact Levi & Korsinsky to Learn More
10:00am, Friday, 28'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
BIIB LAWSUIT ALERT: The Gross Law Firm Notifies Biogen Inc. Investors of a Class Action Lawsuit and Upcoming Deadline
05:45am, Friday, 28'th Jun 2024
NEW YORK , June 28, 2024 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Biogen Inc. (NASDAQ: BIIB). Shareholders who purchased shares of BIIB during the class perio
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
Class Action Filed Against Biogen Inc. (BIIB) Seeking Recovery for Investors - Contact Levi & Korsinsky
05:12am, Friday, 28'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
BIIB SHAREHOLDER ALERT: Bronstein, Gewirtz & Grossman LLC Reminds Biogen Inc. Investors to Join the Class Action Lawsuit
05:00am, Friday, 28'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 28, 2024 / Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Biogen Inc. ("Bi
Contact Levi & Korsinsky by July 22, 2024 Deadline to Join Class Action Against Biogen Inc.(BIIB)
09:15pm, Thursday, 27'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
Eisai and Biogen launch Alzheimer's drug Leqembi in China
09:03pm, Thursday, 27'th Jun 2024
Eisai and Biogen have launched their Alzheimer's treatment Leqembi in China, the third country after the United States and Japan, the companies said on Friday.
“LEQEMBI®” (Lecanemab) for the Treatment of Alzheimer's Disease Launched in China
07:39pm, Thursday, 27'th Jun 2024
China is the Third Country to Launch LEQEMBI Following the United States and Japan China is the Third Country to Launch LEQEMBI Following the United States and Japan
Biogen Inc. Sued for Securities Law Violations – Investors Should Contact Levi & Korsinsky for More Information – BIIB
04:30pm, Thursday, 27'th Jun 2024
NEW YORK, NY / ACCESSWIRE / June 27, 2024 / If you suffered a loss on your Biogen Inc. (NASDAQ:BIIB) investment and want to learn about a potential recovery under the federal securities laws, follow t
Kessler Topaz Meltzer & Check, LLP Reminds Investors of Deadline in Class Action Lawsuit Against Biogen Inc. (BIIB)
04:00pm, Thursday, 27'th Jun 2024
RADNOR, PA / ACCESSWIRE / June 27, 2024 / The law firm of Kessler Topaz Meltzer & Check, LLP(www.ktmc.com) informs investors that a securities class action lawsuit has been filed in the United States
The Schall Law Firm , a national shareholder rights litigation firm, reminds investors of a class action lawsuit against Biogen Inc. ("Biogen" or "the Company") (NASDAQ: BIIB ) for violations of 10(b)
